Skip to main content
Autobound logo
Amgen8-K: Restructuring

Amgen eliminates CTO role, redistributing duties to 3 EVPs effective June 1, 2026.

Read at SEC EDGAR

What happened

The departure of CTO David M. Reese and the splitting of his responsibilities across R&D/AI, Global Markets, and Finance creates a potential leadership vacuum and need for new technology governance.

Source

SEC EDGARApr 22, 2026

Current report (Form 8-K)

Amgen 8-K

Filing excerpt

David M. Reese is retiring from the role of the Company’s Executive Vice President and Chief Technology Officer.

sec.gov/Archives/edgar/data/318154/000031815426000048/amgn-20260422.htmRead the full source

Other signals in this filing (2)

Extracted by Autobound

From the Signal API record
Signal
8-K: Restructuring

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Fiscal year end
04/22
Filed
Apr 22, 2026

More from Amgen

Company page →

More 8-K signals at other companies

The full record

From the Signal API record

Details

CIK
318154
Accession number
0000318154-26-000048
Timeframe
Next quarter
Filing year
2026
Why it matters
Change management needs
Signal category
Workforce

Extraction

Confidence
High
Relevance
90%
Sentiment
Neutral
Detected
Apr 28, 2026
signal_type
sec-8k
signal_subtype
restructuring

Use this data

Get every 8-K signal for Amgen and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Amgen this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/fb5e948d-2ca3-4ac3-825e-7c69c626cc56 returns this record as JSON. POST /v1/companies/enrich returns every signal for amgen.com.

{
  "signal_id": "fb5e948d-2ca3-4ac3-825e-7c69c626cc56",
  "signal_type": "sec-8k",
  "signal_subtype": "restructuring",
  "detected_at": "2026-04-28T10:18:14.219+00:00",
  "company": {
    "name": "Amgen",
    "domain": "amgen.com"
  },
  "data": {
    "detail": "The departure of CTO David M. Reese and the splitting of his responsibilities across R&D/AI, Global Markets, and Finance creates a potential leadership vacuum and need for new technology governance. This change could trigger a review of existing technology vendors and strategies as new leaders establish their roadmaps.",
    "metrics": {
      "timeframe": "next_quarter"
    },
    "summary": "Amgen eliminates CTO role, redistributing duties to 3 EVPs effective June 1, 2026.",
    "excerpts": "David M. Reese is retiring from the role of the Company’s Executive Vice President and Chief Technology Officer.",
    "relevance": 0.9,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/318154/000031815426000048/amgn-20260422.htm",
    "filing_date": "2026-04-22",
    "filing_year": 2026,
    "fiscal_year_end": "04/22",
    "sales_relevance": "Change management needs",
    "signal_category": "workforce"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.